1 Design of Dose Response Clinical Trials Boston Chapter of ASA April 10, 2006 Naitee Ting, Pfizer Global R&D.
Phase I dose escalation studies in Oncology: a call for on-study safety and flexibility Bill Mietlowski, Biometrics and Data Management, Novartis Oncology.
A/Professor Arun Aggarwal Royal Prince Alfred Hospital Pain Management Centre SYDNEY AUSTRALIA International Conference on Pain Medicine 2015 – Chicago.
1 Who Needs Bayesian Phase I Trials? Rick Chappell Professor, Departments of Statistics and of Biostatistics and Medical Informatics University of Wisconsin.
Erik Roelofs MSc Medical Physicist MAASTRO clinic Maastricht, Juli 2011
Cancer.orgPredict Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung.
Cancer Trials. Reading instructions 6.1: Introduction 6.2: General Considerations 6.3: Single stage phase I designs 6.4: Two stage phase I designs 6.5:
